e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Acute exacerbations of COPD: aetiology and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD is associated with high levels of bacterial antibiotic resistance
F. Blasi, R. Cosentini, P. Tarsia, V. Popescu-Janu, C. Gambardella, G. Graziadei, C. Canetta, L. Allegra (Milan, Italy)
Source:
Annual Congress 2002 - Acute exacerbations of COPD: aetiology and therapy
Session:
Acute exacerbations of COPD: aetiology and therapy
Session type:
Thematic Poster Session
Number:
3374
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Blasi, R. Cosentini, P. Tarsia, V. Popescu-Janu, C. Gambardella, G. Graziadei, C. Canetta, L. Allegra (Milan, Italy). COPD is associated with high levels of bacterial antibiotic resistance. Eur Respir J 2002; 20: Suppl. 38, 3374
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of erythromycin resistance in lower airway bacterial isolates from patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Bacterial airway colonization is not associated with increased procalcitonin in stable COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of
S. aureus
and
haemophilus
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
Effects of low load/high-repetition resistance training in patients with COPD
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
LATE-BREAKING ABSTRACT: Haemophilus dominance of the stable COPD microbiome is associated with greater bacterial load and inflammation and is modulated by prophylactic antibiotic therapy
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015
Amoxicillin concentrations in sputum in relation to betalactamase activity in COPD patients
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
The role of increasing bacterial resistance
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Impact of antibiotic consumption in the evolution of respiratory
pseudomonas
antibiotic resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021
Year: 2022
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy.
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept